Login to Your Account



Archimedes' £65M Fundraising Best by EU Biotech in 15 Years

By Nuala Moran


Wednesday, March 3, 2010
LONDON - Archimedes Pharma Ltd. completed the biggest fundraising by a private European biotech in 15 years, raising £65 million (US$96.9 million) to set up U.S. operations and begin commercialization of PecFent, a fast-onset nasal formulation of the pain killer fentanyl. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription